— Know what they know.
Not Investment Advice
Also trades as: GLAB.CN (CNQ) · $vol 0M

GLABF OTC

Gemina Laboratories Ltd.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +0.0% 1Y: -85.1% 3Y: -90.5%
$0.05
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Sell · Power 42 · $3.8M mcap · 44M float · 0.372% daily turnover · Short 66% of daily vol

Balance Sheet Trends

Total Assets
$1M -1.2% ▼
4Y CAGR: -13.1%
Total Liabilities
$6M +93.1% ▲
4Y CAGR: +25.5%
Shareholders Equity
-$4M -179.8% ▼
Cash & Investments
$703 -29.0% ▼
4Y CAGR: -83.3%
Total Debt
$1M +162.4% ▲
4Y CAGR: +89.8%
Net Debt
$1M +162.8% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$882K$1M$83K$990$703
Short-Term Investments$16K$0$0$0$0
Cash & ST Investments$898K$1M$83K$990$703
Net Receivables$16K$10K$0$0$35K
Inventory$2M$0$0$0$0
Other Current Assets$2M$0$0$0$0
Total Current Assets$2M$1M$563K$93K$106K
Property, Plant & Equip.$46K$41K$318K$369K$315K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$10K$0$994K$994K$994K
Other Non-Current Assets$25K$0$0$0$22K
Total Non-Current Assets$81K$41K$1M$1M$1M
Total Assets$3M$1M$2M$1M$1M
— Liabilities —
Accounts Payable$84K$326K$929K$2M$3M
Short-Term Debt$0$0$0$200K$999K
Deferred Revenue$32K$0$0$0$0
Other Current Liabilities$2M$0$0$739K$0
Total Current Liabilities$2M$470K$2M$3M$6M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$38K$5K$198K$206K$175K
Total Liabilities$2M$476K$2M$3M$6M
— Equity —
Common Stock$994K$6M$8M$11M$12M
Retained Earnings-$834K-$6M-$12M-$17M-$21M
Accumulated OCI$0$891K$3M$4M$4M
Total Stockholders Equity$160K$944K-$72K-$2M-$4M
Total Liabilities & Equity$3M$1M$2M$1M$1M
— Key Metrics —
Total Debt$98K$46K$241K$485K$1M
Net Debt-$784K-$1M$158K$484K$1M
Total Investments$26K$0$994K$994K$994K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms